Literature DB >> 17548979

Neuropathologic examination after 91 ECT treatments in a 92-year-old woman with late-onset depression.

Jason Scalia1, Sarah H Lisanby, Andrew J Dwork, James E Johnson, Elisabeth R Bernhardt, Victoria Arango, W Vaughn McCall.   

Abstract

Whereas pathological seizure states, such as temporal lobe epilepsy, are commonly associated with cell loss and glial scarring in the hippocampus, seizures induced via electroconvulsive therapy (ECT) have not been associated with histological evidence of neuronal damage. We present a case report including the late-life medical history and postmortem histology of an elderly woman with major depression who received 91 sessions of ECT during the last 22 years of her life. Given the large number of ECT sessions, and her advanced age, this case provides a strong test of whether ECT causes detectable evidence of neuronal damage. We examined the gross morphology of the hippocampus, hippocampal cytoarchitecture, and measures of neuropathology. We found no pathological changes that could be attributed to ECT. Only expected, age-related features were present. Corpora amylacea and rare neurofibrillary tangles were evident, but we failed to detect any obvious evidence of cell loss or gliosis. Cognition in this patient was intact as indicated by a perfect score on a Mini-Mental Status Examination administered 6 days before death at the age of 92. This case adds to the considerable evidence for the safety of ECT.

Entities:  

Mesh:

Year:  2007        PMID: 17548979     DOI: 10.1097/YCT.0b013e31804bb99d

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  9 in total

Review 1.  Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy.

Authors:  Jiangling Jiang; Jijun Wang; Chunbo Li
Journal:  Neurosci Bull       Date:  2016-12-28       Impact factor: 5.203

2.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

3.  Searching for the mechanism(s) of ECT's therapeutic effect.

Authors:  W Vaughn McCall; Chittaranjan Andrade; Pascal Sienaert
Journal:  J ECT       Date:  2014-06       Impact factor: 3.635

4.  Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy.

Authors:  A J Dwork; J R Christensen; K B Larsen; J Scalia; M D Underwood; V Arango; B Pakkenberg; S H Lisanby
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

Review 5.  Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy.

Authors:  Shawn M McClintock; Jimmy Choi; Zhi-De Deng; Lawrence G Appelbaum; Andrew D Krystal; Sarah H Lisanby
Journal:  J ECT       Date:  2014-06       Impact factor: 3.635

6.  Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.

Authors:  W Vaughn McCall; Sarah H Lisanby; Peter B Rosenquist; Mary Dooley; Mustafa M Husain; Rebecca G Knapp; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Nagy A Youssef; Laryssa McCloud; Charles H Kellner
Journal:  J Psychiatr Res       Date:  2017-11-16       Impact factor: 4.791

7.  The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression.

Authors:  Sanne J H van Rooij; Patricio Riva-Posse; William M McDonald
Journal:  Curr Treat Options Psychiatry       Date:  2020-06-03

8.  Electro-convulsive Therapy: A Few Lingering Thoughts/Doubts!

Authors:  M S Reddy
Journal:  Indian J Psychol Med       Date:  2011-07

9.  First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome.

Authors:  R David Heekin; Kalonda Bradshaw; Chadi A Calarge
Journal:  BMC Psychiatry       Date:  2019-04-24       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.